Physician
Oncology
Dr. Anna Berkenblit, MD
|
|
Give Review
Anna Berkenblit is an expert in the field of Oncology. She researched medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine Anna Berkenblit is also a published doctor. She has 26 publication published. The most recent publication is: Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2-Dependent and Other Solid Tumors.
Publications
- Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2-Dependent and Other Solid Tumors.
- Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial.
- Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or meta...
- Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma.
- Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors.
- Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus.
- Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy.
- Q-TWiST analysis of patients receiving temsirolimus or interferon alpha for treatment of advanced renal cell carcinoma.
- Temsirolimus in mantle cell lymphoma and other non-Hodgkin lymphoma subtypes.
- Clinical trial experience with temsirolimus in patients with advanced renal cell carcinoma.
- Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal ...
- Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.
- Analysis of PTEN and HIF-1alpha and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-alpha.
- Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer.
- Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies.
- Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features.
- Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study.
- Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors.
- Ovarian carcinoma with thyroid metastases causing clinical hypothyroidism: a case report.
- Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer.
- Advances in the management of epithelial ovarian cancer.
- A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial.
- A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.
- The role of topotecan in the treatment of brain metastases.
- Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin.
Schools
Harvard Medical School
Brigham and Women39s Hospital
Beth Israel Deaconess Med Center
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Harvard Medical School
Helpful Reviews
Similar Doctors
|
Dr. Sarah E. Slater, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregg D. Fine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin R. Derose, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth G. Trehu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia A. Sirard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jared A. Gollob, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Burt A. Adelman, MD |
|
|
Dr. Anthony L. Boral, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Pearlberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Vasconcelles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick T. Lee, MD |
|
|
Dr. Debashish Misra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa B. Weissmann, MD
This Doctor is OpenDoctor Recommended.
|